Not Signed In - New Compound May Decrease Vision Loss In Diabetes
Mon, 18 Jul 2005 02:00 AM EST
... A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association''s journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes. Initial results of the Phase III clinical trial demonstrated that 32 milligrams per day of ruboxistaurin (RBX) was well tolerated and may reduce the risk of moderate vision loss, especially in patients with diabetic macular edema. ...
Related Topics
- Decrease or loss of vision
- Low Vision
- Low Vision & Blindness
- Diabetes - Type 1
- Hearing Loss
- Diabetes - Type 2
- Temporary or permanent decrease or loss of other organ functions
- Permanent decrease or loss of sensation in areas of the body
- Diabetes Insipidus
- Aspirin and Carisoprodol
- Gestational Diabetes
- Eyes and Vision
- Diabetes and Pregnancy
- Juvenile Diabetes
- Vision Loss
- Severe vision loss
- Permanent loss of vision, speech, movement
- Permanent vision loss in the affected eye
- Pregnancy Loss
- Vision Impairment
email this page
print this page
bookmark this page
feedback on this page
